J Neurooncol (2006) 80:37–37 DOI 10.1007/s11060-006-9228-8
E RR A T U M
Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) T. S. Armstrong Æ T. Mendoza Æ I. Gning Æ C. Coco Æ M. Z. Cohen Æ L. Eriksen Æ Ming-Ann Hsu Æ M. R. Gilbert Æ C. Cleeland
Published online: 29 August 2006 Ó Springer Science+Business Media B.V. 2006
Erratum to: J Neurooncol DOI 10.1007/s11060-006-9135-z In the original article, the third author’s name was misspelled.
The online version of the original article can be found at http:// dx.doi.org/10.1007/s11060-006-9135-z T. S. Armstrong Æ M. Z. Cohen Æ L. Eriksen The University of Texas Health Science Center at Houston, School of Nursing, Houston, Texas, USA T. Mendoza Æ I. Gning Æ C. Coco Æ M. R. Gilbert Æ C. Cleeland Æ T. S. Armstrong Æ M. Z. Cohen Æ L. Eriksen The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA M.-A. Hsu Pfizer, Inc., New London, Conneticut, USA T. S. Armstrong (&) Neuro-Oncology, Unit 431, UT MDACC, 301402, Houston, Texas 77030, USA e-mail:
[email protected]
123
